Co-Authors
This is a "connection" page, showing publications co-authored by Andrew Badley and John O'Horo.
Connection Strength
4.135
-
A Blueprint to Control the SARS-CoV-2 Pandemic. Mayo Clin Proc. 2021 05; 96(5):1128-1131.
Score: 0.936
-
In reply-Outcomes of COVID-19 With the Mayo Clinic Model of Care and Research. Mayo Clin Proc. 2021 04; 96(4):1092-1093.
Score: 0.928
-
Outcomes of COVID-19 With the Mayo Clinic Model of Care and Research. Mayo Clin Proc. 2021 03; 96(3):601-618.
Score: 0.921
-
Vaccination Safety: Don't Toss the Champagne With the Cork. Mayo Clin Proc. 2021 07; 96(7):1712-1713.
Score: 0.238
-
Association Between Chronic Statin Use and 30-Day Mortality in Hospitalized Patients With COVID-19. Mayo Clin Proc Innov Qual Outcomes. 2021 Apr; 5(2):442-446.
Score: 0.234
-
Intravenous bamlanivimab use associates with reduced hospitalization in high-risk patients with mild to moderate COVID-19. J Clin Invest. 2021 10 01; 131(19).
Score: 0.061
-
Mapping each pre-existing condition's association to short-term and long-term COVID-19 complications. NPJ Digit Med. 2021 Jul 27; 4(1):117.
Score: 0.060
-
Real-time analysis of a mass vaccination effort confirms the safety of FDA-authorized mRNA COVID-19 vaccines. Med (N Y). 2021 Aug 13; 2(8):965-978.e5.
Score: 0.060
-
FDA-authorized mRNA COVID-19 vaccines are effective per real-world evidence synthesized across a multi-state health system. Med (N Y). 2021 Aug 13; 2(8):979-992.e8.
Score: 0.060
-
Anemia during SARS-CoV-2 infection is associated with rehospitalization after viral clearance. iScience. 2021 Jul 23; 24(7):102780.
Score: 0.060
-
Mass Spectrometric Analysis of Urine from COVID-19 Patients for Detection of SARS-CoV-2 Viral Antigen and to Study Host Response. J Proteome Res. 2021 07 02; 20(7):3404-3413.
Score: 0.059
-
Healthcare disparities among anticoagulation therapies for severe COVID-19 patients in the multi-site VIRUS registry. J Med Virol. 2021 Jul; 93(7):4303-4318.
Score: 0.059
-
Pre-existing conditions are associated with COVID-19 patients' hospitalization, despite confirmed clearance of SARS-CoV-2 virus. EClinicalMedicine. 2021 Apr; 34:100793.
Score: 0.058
-
Plasma IL-6 levels following corticosteroid therapy as an indicator of ICU length of stay in critically ill COVID-19 patients. Cell Death Discov. 2021 Mar 15; 7(1):55.
Score: 0.058
-
Enoxaparin is associated with lower rates of mortality than unfractionated Heparin in hospitalized COVID-19 patients. EClinicalMedicine. 2021 Mar; 33:100774.
Score: 0.058
-
Exploratory analysis of immunization records highlights decreased SARS-CoV-2 rates in individuals with recent non-COVID-19 vaccinations. Sci Rep. 2021 02 26; 11(1):4741.
Score: 0.058
-
Statins as an adjunctive therapy for COVID-19: the biological and clinical plausibility. Immunopharmacol Immunotoxicol. 2021 Feb; 43(1):37-50.
Score: 0.058
-
Long-term SARS-CoV-2 RNA shedding and its temporal association to IgG seropositivity. Cell Death Discov. 2020 Dec 02; 6(1):138.
Score: 0.057
-
Inference from longitudinal laboratory tests characterizes temporal evolution of COVID-19-associated coagulopathy (CAC). Elife. 2020 08 17; 9.
Score: 0.056
-
Augmented curation of clinical notes from a massive EHR system reveals symptoms of impending COVID-19 diagnosis. Elife. 2020 07 07; 9.
Score: 0.056